Estanislao Nistal-Villan

14PUBLICATIONS
40CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsMajor global burdens of diseaseInfectious agentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 29, 2025
Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.

Juan García-Bernalt Diego, Javier Arranz-Herrero, Gabriel Laghlali

|Nov 24, 2025
Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.

Juan García-Bernalt Diego, Javier Arranz-Herrero, Gabriel Laghlali

|Nov 05, 2025
Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma.

Vicent Tur-Planells, Yonina Bykov, Gloria Dawodu

|Jan 08, 2025
Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention.

Jesus Presa, Javier Arranz-Herrero, Laura Alvarez-Losa

|Dec 05, 2023
Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics.

Marina Robas, Jesús Presa, Javier Arranz-Herrero

|Oct 28, 2023
Engineering Non-Human RNA Viruses for Cancer Therapy.

Vicent Tur-Planells, Adolfo García-Sastre, Sara Cuadrado-Castano

Pageof 3